Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children.

Root ED, Lucero M, Nohynek H, Anthamatten P, Thomas DS, Tallo V, Tanskanen A, Quiambao BP, Puumalainen T, Lupisan SP, Ruutu P, Ladesma E, Williams GM, Riley I, Simões EA.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3520-5. doi: 10.1073/pnas.1313748111. Epub 2014 Feb 18.

2.

Distance to health services modifies the effect of an 11-valent pneumococcal vaccine on pneumonia risk among children less than 2 years of age in Bohol, Philippines.

Root ED, Lucero M, Nohynek H, Stubbs R, Tallo V, Lupisan SP, Sanvictores DM, Nillos LT, Simões EA; ARIVAC Team.

Int J Epidemiol. 2017 Apr 1;46(2):706-716. doi: 10.1093/ije/dyw217.

PMID:
27605588
3.

Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.

Lucero MG, Nohynek H, Williams G, Tallo V, Simões EA, Lupisan S, Sanvictores D, Forsyth S, Puumalainen T, Ugpo J, Lechago M, de Campo M, Abucejo-Ladesma E, Sombrero L, Nissinen A, Soininen A, Ruutu P, Riley I, Mäkelä HP.

Pediatr Infect Dis J. 2009 Jun;28(6):455-62. doi: 10.1097/INF.0b013e31819637af.

PMID:
19483514
4.

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA; Gambian Pneumococcal Vaccine Trial Group.

Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46. Erratum in: Lancet. 2005 Jul 2-8;366(9479):28.

PMID:
15794968
5.

IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.

Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H; ARIVAC Consortium.

Vaccine. 2009 May 5;27(20):2680-8. doi: 10.1016/j.vaccine.2009.02.059. Epub 2009 Feb 24.

PMID:
19428879
6.

Pneumococcal conjugate vaccines in the prevention of childhood pneumonia.

Ivády B.

Acta Microbiol Immunol Hung. 2010 Mar;57(1):1-13. doi: 10.1556/AMicr.57.2010.1.1. Review.

PMID:
20350875
7.

Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.

Tyo KR, Rosen MM, Zeng W, Yap M, Pwee KH, Ang LW, Shepard DS.

Vaccine. 2011 Sep 2;29(38):6686-94. doi: 10.1016/j.vaccine.2011.06.091. Epub 2011 Jul 13.

PMID:
21745516
8.

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines.

Sanvictores DH, Lucero MG, Nohynek H, Tallo VL, Tanskanen A, Nillos LT, Williams G; ARIVAC Consortium.

BMC Res Notes. 2012 Jun 7;5:274. doi: 10.1186/1756-0500-5-274.

9.

Pneumococcal conjugate vaccine--a health priority.

Zar HJ, Madhi SA.

S Afr Med J. 2008 Jun;98(6):463-7.

PMID:
18683380
10.

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age.

Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreño RA, Nohynek H, Riley ID, Makela H.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004977. doi: 10.1002/14651858.CD004977.pub2. Review.

PMID:
19821336
11.

Radiology quality assurance in a developing country setting: the 11-valent pneumococcal conjugate vaccine trial, Bohol, Philippines.

Arcay JD, Ocampo AF, Solis RK, Oncog IB, Diaz AD, Epe AC, Cagadas R, Pabatang S, Ostensen H, Lucero MG; Acute Respiratory Infections Vaccines (ARIVAC) Consortium.

Vaccine. 2007 Mar 22;25(13):2528-32. Epub 2006 Sep 20.

PMID:
17023097
12.

Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.

Lucero MG, Dulalia VE, Parreno RN, Lim-Quianzon DM, Nohynek H, Makela H, Williams G.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004977. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004977.

PMID:
15495133
13.

The effect of distance on observed mortality, childhood pneumonia and vaccine efficacy in rural Gambia.

Zaman SM, Cox J, Enwere GC, Bottomley C, Greenwood BM, Cutts FT.

Epidemiol Infect. 2014 Dec;142(12):2491-500. doi: 10.1017/S0950268814000314. Epub 2014 Feb 24.

PMID:
24565180
14.

Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.

Palmu AA, Rinta-Kokko H, Nohynek H, Nuorti JP, Kilpi TM, Jokinen J.

PLoS One. 2017 Mar 1;12(3):e0172690. doi: 10.1371/journal.pone.0172690. eCollection 2017.

15.

Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.

Diaz J, Terrazas S, Bierrenbach AL, Toscano CM, Alencar GP, Alvarez A, Valenzuela MT, Andrus J, del Aguila R, Hormazábal JC, Araya P, Pidal P, Matus CR, de Oliveira LH.

PLoS One. 2016 Apr 8;11(4):e0153141. doi: 10.1371/journal.pone.0153141. eCollection 2016.

16.

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, Noyes J, Lewis E, Ray P, Lee J, Hackell J.

Pediatr Infect Dis J. 2002 Sep;21(9):810-5.

PMID:
12352800
17.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.

Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S140-51. doi: 10.1097/INF.0000000000000082. Review.

18.

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.

Madhi SA, Kuwanda L, Cutland C, Klugman KP.

Clin Infect Dis. 2005 May 15;40(10):1511-8. Epub 2005 Apr 7.

PMID:
15844075
19.

[Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression.]

Guchev IA.

Antibiot Khimioter. 2016;61(7-8):48-57. Review. Russian.

PMID:
29533560
20.

First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial.

Collins AM, Wright AD, Mitsi E, Gritzfeld JF, Hancock CA, Pennington SH, Wang D, Morton B, Ferreira DM, Gordon SB.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):853-8. doi: 10.1164/rccm.201503-0542OC.

PMID:
26114410

Supplemental Content

Support Center